Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae1069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Karen L Kanke und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43215, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, DNA, Single-Stranded, Gene Knock-In Techniques, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Comprehensive Transplant Center Human Tissue Biorepository, OSU Wexner Medical Center, NHLBI NIH HHS, National Institute of Diabetes, Digestive and Kidney Diseases.
Abstract (Originalsprache)
Single-stranded DNA (ssDNA) templates along with Cas9 have been used for knocking-in exogenous sequences in the genome but suffer from low efficiency. Here, we show that ssDNA with chemical modifications in 12–19% of internal bases, which we denote as enhanced ssDNA (esDNA), improve knock-in (KI) by 2–3-fold compared to end-modified ssDNA in airway basal stem cells (ABCs), CD34 + hematopoietic cells (CD34 + cells), T-cells and endothelial cells. Over 50% of alleles showed KI in three clinically relevant loci (CFTR, HBB and CCR5) in ABCs using esDNA and up to 70% of alleles showed KI in the HBB locus in CD34 + cells in the presence of a DNA-PKcs inhibitor. This level of correction is therapeutically relevant and is comparable to adeno-associated virus-based templates. The esDNA templates did not improve KI in induced pluripotent stem cells (iPSCs). This may be due to the absence of the nuclease TREX1 in iPSCs. Indeed, knocking out TREX1 in other cells improved KI using unmodified ssDNA. esDNA can be used to modify 20–30 bp regions in primary cells for therapeutic applications and biological modeling. The use of this approach for gene length insertions will require new methods to produce long chemically modified ssDNA in scalable quantities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43215, USA.
- Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA.
- Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43215, USA.
- Department of Pediatrics, The Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Sriram Vaidyanathan
Förderung
- Comprehensive Transplant Center Human Tissue Biorepository, OSU Wexner Medical Center
- NHLBI NIH HHS
- National Institute of Diabetes, Digestive and Kidney Diseases
- Center for Clinical and Translational Science
- Ohio State University
- Nationwide Children's Hospital
- Cystic Fibrosis Foundation
- NCATS NIH HHS
Zitieren
APA
Kanke, K. L., Rayner, R. E., Bozik, J., Abel, E., Venugopalan, A., Suu, M., Nouri, R., Stack, J. T., Guo, G., Vetter, T. A., Cormet-Boyaka, E., Hester, M. E., & Vaidyanathan, S. (2024). Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1069
Vancouver
Kanke KL, Rayner RE, Bozik J, Abel E, Venugopalan A, Suu M, et al. Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae1069
BibTeX
@article{Kanke2024,
author = {Kanke, Karen L and Rayner, Rachael E and Bozik, Jack and Abel, Eli and Venugopalan, Aparna and Suu, Ma and Nouri, Reza and Stack, Jacob T and Guo, Gongbo and Vetter, Tatyana A and Cormet-Boyaka, Estelle and Hester, Mark E and Vaidyanathan, Sriram},
title = {Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using CRISPR-Cas9},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae1069}
}
EUVIMED